JONATHAN PFEIFER: Open Payments
NPI 1235330374 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 86 payments from 15 companies in 2025. Trend: 2023 $1,392 · 2024 $1,596 · 2025 $1,769
Food & beverage: $1,769
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $441 |
| Corium, LLC | 12 | $231 |
| Almatica Pharma LLC | 9 | $205 |
| ABBVIE INC. | 16 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $159 |
| Janssen Pharmaceuticals, Inc | 6 | $120 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| ACADIA Pharmaceuticals Inc | 3 | $59 |
Products named: FANAPT, Azstarys, LOREEV XR, VRAYLAR, CAPLYTA, SPRAVATO, INGREZZA, REXULTI.
Industry payments across AL — which companies pay providers there.
